Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biol Chem ; 288(18): 12866-79, 2013 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-23504328

RESUMEN

Epstein-Barr virus (EBV) encodes a transcription factor, Rta, which is required to activate the transcription of EBV lytic genes. This study demonstrates that treating P3HR1 cells with a proteasome inhibitor, MG132, causes the accumulation of SUMO-Rta and promotes the expression of EA-D. GST pulldown and coimmunoprecipitation studies reveal that RNF4, a RING-domain-containing ubiquitin E3 ligase, interacts with Rta. RNF4 also targets SUMO-2-conjugated Rta and promotes its ubiquitination in vitro. Additionally, SUMO interaction motifs in RNF4 are important to the ubiquitination of Rta because the RNF4 mutant with a mutation at the motifs eliminates ubiquitination. The mutation of four lysine residues on Rta that abrogated SUMO-3 conjugation to Rta also decreases the enhancement of the ubiquitination of Rta by RNF4. This finding demonstrates that RNF4 is a SUMO-targeted ubiquitin E3 ligase of Rta. Finally, knockdown of RNF4 enhances the expression of Rta and EA-D, subsequently promoting EBV lytic replication and virions production. Results of this study significantly contribute to efforts to elucidate a SUMO-targeted ubiquitin E3 ligase that regulates Rta ubiquitination to influence the lytic development of EBV.


Asunto(s)
Infecciones por Virus de Epstein-Barr/metabolismo , Herpesvirus Humano 4/fisiología , Proteínas Inmediatas-Precoces/metabolismo , Proteínas Nucleares/metabolismo , Transactivadores/metabolismo , Factores de Transcripción/metabolismo , Ubiquitinación , Replicación Viral/fisiología , Secuencias de Aminoácidos , Línea Celular , Infecciones por Virus de Epstein-Barr/genética , Técnicas de Silenciamiento del Gen , Humanos , Proteínas Inmediatas-Precoces/genética , Mutación , Proteínas Nucleares/genética , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/genética , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/metabolismo , Transactivadores/genética , Factores de Transcripción/genética , Ubiquitinas/genética , Ubiquitinas/metabolismo
2.
Biochem Biophys Res Commun ; 447(1): 83-8, 2014 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-24695317

RESUMEN

RNF4, a SUMO-targeted ubiquitin ligase (STUbL), localizes to the nucleus and functions in the DNA damage response during interphase of the cell cycle. RNF4 also exists in cells undergoing mitosis, where its regulation and function remain poorly understood. Here we showed that administration of etoposide, an anticancer DNA topoisomerase II poison, to mitotic human cervical cancer HeLa cells induced SUMO-2/3-dependent localization of RNF4 to chromosomes. The FK2 antibody signals, indicative of poly/multi-ubiquitin assembly, were detected on etoposide-exposed mitotic chromosomes, whereas the signals were negligible in cells depleted for RNF4 by RNA interference. This suggests that RNF4 functions as a STUbL in the etoposide-induced damage response during mitosis. Indeed, RNF4-depletion sensitized mitotic HeLa cells to etoposide and increased cells with micronuclei. These results indicate the importance of the RNF4-mediated STUbL pathway during mitosis for the maintenance of chromosome integrity and further implicate RNF4 as a target for topo II poison-based therapy for cancer patients.


Asunto(s)
Cromosomas Humanos/metabolismo , Etopósido/farmacología , Proteínas Nucleares/metabolismo , Factores de Transcripción/metabolismo , Animales , Reparación del ADN , ADN-Topoisomerasas de Tipo II , Células HEK293 , Células HeLa , Humanos , Ratones , Micronúcleos con Defecto Cromosómico/inducido químicamente , Mitosis , Proteínas Nucleares/efectos de los fármacos , Proteínas Nucleares/inmunología , Proteína SUMO-1/inmunología , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/inmunología , Factores de Transcripción/efectos de los fármacos , Factores de Transcripción/inmunología
3.
Biochem Biophys Res Commun ; 447(3): 419-24, 2014 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-24727457

RESUMEN

Thymine DNA glycosylase (TDG) is a base excision repair enzyme that interacts with the small ubiquitin-related modifier (SUMO)-targeted ubiquitin E3 ligase RNF4 and functions in the active DNA demethylation pathway. Here we showed that both SUMOylated and non-modified forms of endogenous TDG fluctuated during the cell cycle and in response to drugs that perturbed cell cycle progression, including hydroxyurea and nocodazole. Additionally, we detected a SUMOylation-independent association between TDG and RNF4 in vitro as well as in vivo, and observed that both forms of TDG were efficiently degraded in RNF4-depleted cells when arrested at S phase. Our findings provide insights into the in vivo dynamics of TDG SUMOylation and further clarify the TDG-RNF4 interaction.


Asunto(s)
Metilación de ADN , Proteínas Nucleares/metabolismo , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/metabolismo , Sumoilación , Timina ADN Glicosilasa/metabolismo , Factores de Transcripción/metabolismo , Ciclo Celular/efectos de los fármacos , Células Cultivadas , Humanos , Hidroxiurea/farmacología , Mutación , Nocodazol/farmacología , Timina ADN Glicosilasa/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA